Drug therapy of migraine.
D000281:Administration, Intranasal; D000284:Administration, Oral; D000336:Aerosols; D003533:Cyproheptadine / Q000627:therapeutic use; D003937:Diagnosis, Differential; D004878:Ergotamine / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D007273:Injections, Intramuscular; D008784:Methysergide / Q000627:therapeutic use; D008881:Migraine Disorders / Q000175:diagnosis / Q000188:drug therapy* / Q000235:genetics / Q000517:prevention & control; D012702:Serotonin Antagonists; D013488:Suppositories
D000336:Aerosols; D012702:Serotonin Antagonists; D013488:Suppositories; D003533:Cyproheptadine; D004878:Ergotamine; D008784:Methysergide